ClinicalTrials.Veeva

Menu

Regional Anesthesia EMG Study

Nationwide Children's Hospital logo

Nationwide Children's Hospital

Status

Active, not recruiting

Conditions

Surgery

Treatments

Drug: Clonidine
Device: BlockSynop surface electromyography device
Drug: Sevoflurane

Study type

Interventional

Funder types

Other

Identifiers

NCT06287151
STUDY00002844

Details and patient eligibility

About

This study aims to investigate how non-invasive, non-significant risk EMG monitoring can be used intraoperatively to objectively characterize neuraxial anesthesia (i.e. spinal and caudal blockade) in pediatric patients undergoing surgery. The investigators will also attempt to measure the effect of adjunctive intrathecal clonidine on spinal and caudal blockade using EMG. This study also aims to quantify the impact of sevoflurane on basal muscle tone based on EMG changes. This study aims to generate pilot data on this subject to help design future studies.

Full description

This study aims to investigate how non-invasive, non-significant risk EMG monitoring can be used intraoperatively to objectively characterize neuraxial anesthesia (i.e. spinal and caudal blockade) in pediatric patients undergoing surgery. The investigators will also attempt to measure the effect of adjunctive intrathecal clonidine on spinal and caudal blockade using EMG. This study also aims to quantify the impact of sevoflurane on basal muscle tone based on EMG changes. This study aims to generate pilot data on this subject to help design future studies. The hypothesis is that EMG monitoring can be utilized to objectively measure neuraxial blockade, including onset, resolution, density, and dermatomal level.

Enrollment

80 patients

Sex

All

Ages

Under 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Group 1 (GA + penile block): age 5 years or below getting: circumcision or circumcision revision
  • Group 2-5 (SA or GA + CA): age 5 years or below getting: penile or scrotal surgery, inguinal hernia repair, Achilles tendon lengthening, other applicable urological procedures
  • Group 6 (GA only): age 5 years or below getting: operative dentistry, urological or ENT procedures

Exclusion criteria

  • parent refusal
  • systemic infection
  • spine or CNS abnormalities
  • medication allergy
  • adhesive allergy

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 6 patient groups

General Anesthesia with Penile Block
Active Comparator group
Description:
Penile block: prior to the start of surgery 0.5mg/kg of 0.25% bupivacaine w/o epinephrine will be administered GA : Inhalation induction with sevoflurane followed by peripheral IV access, and placement of an endotracheal tube or laryngeal mask airway. No intravenous neuromuscular blockade will be given. Sevoflurane is FDA approved for the induction and maintenance of general anesthesia in adults and pediatric patients.
Treatment:
Device: BlockSynop surface electromyography device
Spinal Anesthesia with Clonidine
Active Comparator group
Description:
Spinal block: 0.5% isobaric bupivacaine with 1:200,000 epinephrine (0.2mL/kg up to 1mL), with or without 1mcg/kg clonidine Clonidine is an FDA approved medication that is commonly administered as an adjunct to SA and CA in this population.
Treatment:
Device: BlockSynop surface electromyography device
Drug: Clonidine
Spinal Anesthesia without Clonidine
Active Comparator group
Description:
Spinal block: 0.5% isobaric bupivacaine with 1:200,000 epinephrine (0.2mL/kg up to 1mL), with or without 1mcg/kg clonidine
Treatment:
Device: BlockSynop surface electromyography device
General Anesthesia with Caudal Anesthesia with Clonidine
Active Comparator group
Description:
Caudal block: single-shot caudal injection following induction of GA with 1mL/kg of 0.25% bupivacaine with 1:200,000 epinephrine, with or without clonidine 1mcg/kg Clonidine is an FDA approved medication that is commonly administered as an adjunct to SA and CA in this population.
Treatment:
Drug: Sevoflurane
Device: BlockSynop surface electromyography device
Drug: Clonidine
General Anesthesia with Caudal Anesthesia without Clonidine
Active Comparator group
Description:
Caudal block: single-shot caudal injection following induction of GA with 1mL/kg of 0.25% bupivacaine with 1:200,000 epinephrine, with or without clonidine 1mcg/kg
Treatment:
Drug: Sevoflurane
Device: BlockSynop surface electromyography device
General Anesthesia only
Active Comparator group
Description:
GA alone: Inhalation induction with sevoflurane followed by peripheral IV access, and placement of an endotracheal tube or laryngeal mask airway. No intravenous neuromuscular blockade will be given. Sevoflurane is FDA approved for the induction and maintenance of general anesthesia in adults and pediatric patients.
Treatment:
Drug: Sevoflurane
Device: BlockSynop surface electromyography device

Trial contacts and locations

1

Loading...

Central trial contact

Julie Rice-Weimer; Catherine Roth

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems